1. Home
  2. GPCR vs BASE Comparison

GPCR vs BASE Comparison

Compare GPCR & BASE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • GPCR
  • BASE
  • Stock Information
  • Founded
  • GPCR 2016
  • BASE 2011
  • Country
  • GPCR United States
  • BASE United States
  • Employees
  • GPCR N/A
  • BASE N/A
  • Industry
  • GPCR
  • BASE EDP Services
  • Sector
  • GPCR
  • BASE Technology
  • Exchange
  • GPCR Nasdaq
  • BASE Nasdaq
  • Market Cap
  • GPCR 1.1B
  • BASE 1.0B
  • IPO Year
  • GPCR 2023
  • BASE 2021
  • Fundamental
  • Price
  • GPCR $21.76
  • BASE $18.07
  • Analyst Decision
  • GPCR Strong Buy
  • BASE Buy
  • Analyst Count
  • GPCR 8
  • BASE 15
  • Target Price
  • GPCR $79.29
  • BASE $21.07
  • AVG Volume (30 Days)
  • GPCR 755.1K
  • BASE 511.5K
  • Earning Date
  • GPCR 05-08-2025
  • BASE 06-03-2025
  • Dividend Yield
  • GPCR N/A
  • BASE N/A
  • EPS Growth
  • GPCR N/A
  • BASE N/A
  • EPS
  • GPCR N/A
  • BASE N/A
  • Revenue
  • GPCR N/A
  • BASE $209,466,000.00
  • Revenue This Year
  • GPCR N/A
  • BASE $12.08
  • Revenue Next Year
  • GPCR N/A
  • BASE $13.60
  • P/E Ratio
  • GPCR N/A
  • BASE N/A
  • Revenue Growth
  • GPCR N/A
  • BASE 16.35
  • 52 Week Low
  • GPCR $13.22
  • BASE $12.78
  • 52 Week High
  • GPCR $62.74
  • BASE $25.18
  • Technical
  • Relative Strength Index (RSI)
  • GPCR 39.75
  • BASE 54.88
  • Support Level
  • GPCR $22.09
  • BASE $17.89
  • Resistance Level
  • GPCR $24.98
  • BASE $19.28
  • Average True Range (ATR)
  • GPCR 1.64
  • BASE 0.55
  • MACD
  • GPCR -0.54
  • BASE -0.12
  • Stochastic Oscillator
  • GPCR 4.64
  • BASE 30.46

About GPCR Structure Therapeutics Inc.

Structure Therapeutics Inc is a clinical-stage biopharmaceutical company developing novel oral small-molecule therapeutics to treat a wide range of chronic diseases with unmet medical needs. Its differentiated technology platform leverages both structure-based drug discovery and expertise in computational chemistry to discover and develop small molecule therapeutics against G-protein coupled receptors (GPCRs). The group operates and manages its business as one reportable and operating segment, which is the business of research and development of medicines that target chronic diseases with unmet medical needs.

About BASE Couchbase Inc.

Couchbase Inc provides a modern cloud database that offers the robust capabilities required for business-critical applications on a scalable and available platform. It empower developers and architects to build, deploy and run mission-critical applications. Couchbase delivers a high-performance, flexible and scalable modern database that runs across the data center and any cloud. Geographically, the company generates a majority of its revenue from the United States.

Share on Social Networks: